153 related articles for article (PubMed ID: 35799671)
1. Discovering Gene Signature Shared by Prostate Cancer and Neurodegenerative Diseases Based on the Bioinformatics Approach.
Su Q; Dai B; Zhang H; Zhang S
Comput Math Methods Med; 2022; 2022():8430485. PubMed ID: 35799671
[TBL] [Abstract][Full Text] [Related]
2. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
[TBL] [Abstract][Full Text] [Related]
3. MYLK and CALD1 as molecular targets in bladder cancer.
Jin H; Liu B; Guo X; Qiao X; Jiao W; Yang L; Song X; Wei Y; Jin T
Medicine (Baltimore); 2023 Nov; 102(47):e36302. PubMed ID: 38013282
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of biomarkers for prostate cancer based on weighted gene co-expression network analysis.
Chen X; Wang J; Peng X; Liu K; Zhang C; Zeng X; Lai Y
Medicine (Baltimore); 2020 Apr; 99(14):e19628. PubMed ID: 32243390
[TBL] [Abstract][Full Text] [Related]
5. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analysis identified hub genes in prostate cancer tumorigenesis and metastasis.
Gu P; Yang D; Zhu J; Zhang M; He X
Math Biosci Eng; 2021 Apr; 18(4):3180-3196. PubMed ID: 34198380
[TBL] [Abstract][Full Text] [Related]
7. The Identification of Key Gene Expression Signature in Prostate Cancer.
Huang Y; Cao Q; Song Z; Ruan H; Wang K; Chen K; Zhang X
Crit Rev Eukaryot Gene Expr; 2020; 30(2):153-168. PubMed ID: 32558494
[TBL] [Abstract][Full Text] [Related]
8. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
9. [Bioinformatics-based identification of the key genes associated with prostate cancer].
Zhao HB; Xu GB; Yang WQ; Li XZ; Chen SX; Gan Y; Su ZM; Sheng M; Zeng YR
Zhonghua Nan Ke Xue; 2021 Jun; 27(6):489-498. PubMed ID: 34914287
[TBL] [Abstract][Full Text] [Related]
10. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
[TBL] [Abstract][Full Text] [Related]
11. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
13. Identification of Hub Genes Associated with Progression and Prognosis of Bladder Cancer by Integrated Bioinformatics Analysis.
Jiang S; Ma J; Wei S; Ren P; Liu J; Zhou Y; Liu D; Zhang X
Arch Esp Urol; 2022 Nov; 75(9):779-790. PubMed ID: 36472061
[TBL] [Abstract][Full Text] [Related]
14. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
[TBL] [Abstract][Full Text] [Related]
15. Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
Xu Z; Jiang P; He S
Med Sci Monit; 2019 Dec; 25():9216-9226. PubMed ID: 31794546
[TBL] [Abstract][Full Text] [Related]
16. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
17. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
18. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice.
Zhao J; He K; Du H; Wei G; Wen Y; Wang J; Zhou X; Wang J
PeerJ; 2022; 10():e13932. PubMed ID: 36157062
[TBL] [Abstract][Full Text] [Related]
20. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
Fang E; Zhang X; Wang Q; Wang D
Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]